カテゴリ：世界, 医療/バイオ, QYResearch

線維腺腫診断の世界市場インサイト・予測（～2028年）

■ 英語タイトル：Global Fibroadenoma Diagnosis Market Insights, Forecast to 2028
	■ 発行会社/調査会社：QYResearch ■ 商品コード：QY22JL3460 ■ 発行日：2022年7月（※2025年版があります。お問い合わせください。） ■ 調査対象地域：グローバル ■ 産業分野：医療 ■ ページ数：92 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後3営業日）

■ 販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD4,900 ⇒換算￥744,800	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD7,350 ⇒換算￥1,117,200	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD9,800 ⇒換算￥1,489,600	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[線維腺腫診断の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせはこちら

*** レポート概要（サマリー）***

COVID-19のパンデミックにより、線維腺腫診断のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に線維腺腫診断の世界市場のxxx％を占める「診断マンモグラフィ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
線維腺腫診断の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの線維腺腫診断市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

線維腺腫診断のグローバル主要企業には、The Royal Woman's Hospital、Westmead Breast Cancer Institute、HCA Healthcare、Breast Cancer Now、UFHealth、KK Women's and Children's Hospital、The Harley Street Breast Clinic、National University Health System、American Cancer Societyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

線維腺腫診断市場は、種類と用途によって区分されます。世界の線維腺腫診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
診断マンモグラフィ、乳房超音波、穿刺吸引生検、コア針生検

【用途別セグメント】
病院、個人クリニック、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 線維腺腫診断製品概要
- 種類別市場（診断マンモグラフィ、乳房超音波、穿刺吸引生検、コア針生検）
- 用途別市場（病院、個人クリニック、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の線維腺腫診断販売量予測2017-2028
- 世界の線維腺腫診断売上予測2017-2028
- 線維腺腫診断の地域別販売量
- 線維腺腫診断の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別線維腺腫診断販売量
- 主要メーカー別線維腺腫診断売上
- 主要メーカー別線維腺腫診断価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（診断マンモグラフィ、乳房超音波、穿刺吸引生検、コア針生検）
- 線維腺腫診断の種類別販売量
- 線維腺腫診断の種類別売上
- 線維腺腫診断の種類別価格
・用途別市場規模（病院、個人クリニック、その他）
- 線維腺腫診断の用途別販売量
- 線維腺腫診断の用途別売上
- 線維腺腫診断の用途別価格
・北米市場
- 北米の線維腺腫診断市場規模（種類別、用途別）
- 主要国別の線維腺腫診断市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの線維腺腫診断市場規模（種類別、用途別）
- 主要国別の線維腺腫診断市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の線維腺腫診断市場規模（種類別、用途別）
- 主要国別の線維腺腫診断市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の線維腺腫診断市場規模（種類別、用途別）
- 主要国別の線維腺腫診断市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの線維腺腫診断市場規模（種類別、用途別）
- 主要国別の線維腺腫診断市場規模（トルコ、サウジアラビア）
・企業情報
The Royal Woman's Hospital、Westmead Breast Cancer Institute、HCA Healthcare、Breast Cancer Now、UFHealth、KK Women's and Children's Hospital、The Harley Street Breast Clinic、National University Health System、American Cancer Society
・産業チェーン及び販売チャネル分析
- 線維腺腫診断の産業チェーン分析
- 線維腺腫診断の原材料
- 線維腺腫診断の生産プロセス
- 線維腺腫診断の販売及びマーケティング
- 線維腺腫診断の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 線維腺腫診断の産業動向
- 線維腺腫診断のマーケットドライバー
- 線維腺腫診断の課題
- 線維腺腫診断の阻害要因
・主な調査結果

Market Analysis and Insights: Global Fibroadenoma Diagnosis Market
The global Fibroadenoma Diagnosis market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Diagnostic Mammography accounting for % of the Fibroadenoma Diagnosis global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Fibroadenoma Diagnosis market size is valued at US$ million in 2021, while the North America and Europe Fibroadenoma Diagnosis are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Fibroadenoma Diagnosis landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fibroadenoma Diagnosis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fibroadenoma Diagnosis market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fibroadenoma Diagnosis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fibroadenoma Diagnosis market.
Global Fibroadenoma Diagnosis Scope and Market Size
Fibroadenoma Diagnosis market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Fibroadenoma Diagnosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Diagnostic Mammography
Breast Ultrasound
Fine-needle Aspiration
Core Needle Biopsy
Segment by Application
Hospitals
Private Clinics
Others
By Company
The Royal Woman’s Hospital
Westmead Breast Cancer Institute
HCA Healthcare
Breast Cancer Now
UFHealth
KK Women’s and Children’s Hospital
The Harley Street Breast Clinic
National University Health System
American Cancer Society
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

*** レポート目次（コンテンツ）***

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fibroadenoma Diagnosis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Diagnostic Mammography
1.2.3 Breast Ultrasound
1.2.4 Fine-needle Aspiration
1.2.5 Core Needle Biopsy
1.3 Market by Application
1.3.1 Global Fibroadenoma Diagnosis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Private Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fibroadenoma Diagnosis Market Perspective (2017-2028)
2.2 Fibroadenoma Diagnosis Growth Trends by Region
2.2.1 Fibroadenoma Diagnosis Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fibroadenoma Diagnosis Historic Market Size by Region (2017-2022)
2.2.3 Fibroadenoma Diagnosis Forecasted Market Size by Region (2023-2028)
2.3 Fibroadenoma Diagnosis Market Dynamics
2.3.1 Fibroadenoma Diagnosis Industry Trends
2.3.2 Fibroadenoma Diagnosis Market Drivers
2.3.3 Fibroadenoma Diagnosis Market Challenges
2.3.4 Fibroadenoma Diagnosis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fibroadenoma Diagnosis Players by Revenue
3.1.1 Global Top Fibroadenoma Diagnosis Players by Revenue (2017-2022)
3.1.2 Global Fibroadenoma Diagnosis Revenue Market Share by Players (2017-2022)
3.2 Global Fibroadenoma Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fibroadenoma Diagnosis Revenue
3.4 Global Fibroadenoma Diagnosis Market Concentration Ratio
3.4.1 Global Fibroadenoma Diagnosis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fibroadenoma Diagnosis Revenue in 2021
3.5 Fibroadenoma Diagnosis Key Players Head office and Area Served
3.6 Key Players Fibroadenoma Diagnosis Product Solution and Service
3.7 Date of Enter into Fibroadenoma Diagnosis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fibroadenoma Diagnosis Breakdown Data by Type
4.1 Global Fibroadenoma Diagnosis Historic Market Size by Type (2017-2022)
4.2 Global Fibroadenoma Diagnosis Forecasted Market Size by Type (2023-2028)
5 Fibroadenoma Diagnosis Breakdown Data by Application
5.1 Global Fibroadenoma Diagnosis Historic Market Size by Application (2017-2022)
5.2 Global Fibroadenoma Diagnosis Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fibroadenoma Diagnosis Market Size (2017-2028)
6.2 North America Fibroadenoma Diagnosis Market Size by Type
6.2.1 North America Fibroadenoma Diagnosis Market Size by Type (2017-2022)
6.2.2 North America Fibroadenoma Diagnosis Market Size by Type (2023-2028)
6.2.3 North America Fibroadenoma Diagnosis Market Share by Type (2017-2028)
6.3 North America Fibroadenoma Diagnosis Market Size by Application
6.3.1 North America Fibroadenoma Diagnosis Market Size by Application (2017-2022)
6.3.2 North America Fibroadenoma Diagnosis Market Size by Application (2023-2028)
6.3.3 North America Fibroadenoma Diagnosis Market Share by Application (2017-2028)
6.4 North America Fibroadenoma Diagnosis Market Size by Country
6.4.1 North America Fibroadenoma Diagnosis Market Size by Country (2017-2022)
6.4.2 North America Fibroadenoma Diagnosis Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Fibroadenoma Diagnosis Market Size (2017-2028)
7.2 Europe Fibroadenoma Diagnosis Market Size by Type
7.2.1 Europe Fibroadenoma Diagnosis Market Size by Type (2017-2022)
7.2.2 Europe Fibroadenoma Diagnosis Market Size by Type (2023-2028)
7.2.3 Europe Fibroadenoma Diagnosis Market Share by Type (2017-2028)
7.3 Europe Fibroadenoma Diagnosis Market Size by Application
7.3.1 Europe Fibroadenoma Diagnosis Market Size by Application (2017-2022)
7.3.2 Europe Fibroadenoma Diagnosis Market Size by Application (2023-2028)
7.3.3 Europe Fibroadenoma Diagnosis Market Share by Application (2017-2028)
7.4 Europe Fibroadenoma Diagnosis Market Size by Country
7.4.1 Europe Fibroadenoma Diagnosis Market Size by Country (2017-2022)
7.4.2 Europe Fibroadenoma Diagnosis Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fibroadenoma Diagnosis Market Size (2017-2028)
8.2 Asia-Pacific Fibroadenoma Diagnosis Market Size by Type
8.2.1 Asia-Pacific Fibroadenoma Diagnosis Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Fibroadenoma Diagnosis Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Fibroadenoma Diagnosis Market Share by Type (2017-2028)
8.3 Asia-Pacific Fibroadenoma Diagnosis Market Size by Application
8.3.1 Asia-Pacific Fibroadenoma Diagnosis Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Fibroadenoma Diagnosis Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Fibroadenoma Diagnosis Market Share by Application (2017-2028)
8.4 Asia-Pacific Fibroadenoma Diagnosis Market Size by Region
8.4.1 Asia-Pacific Fibroadenoma Diagnosis Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Fibroadenoma Diagnosis Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Fibroadenoma Diagnosis Market Size (2017-2028)
9.2 Latin America Fibroadenoma Diagnosis Market Size by Type
9.2.1 Latin America Fibroadenoma Diagnosis Market Size by Type (2017-2022)
9.2.2 Latin America Fibroadenoma Diagnosis Market Size by Type (2023-2028)
9.2.3 Latin America Fibroadenoma Diagnosis Market Share by Type (2017-2028)
9.3 Latin America Fibroadenoma Diagnosis Market Size by Application
9.3.1 Latin America Fibroadenoma Diagnosis Market Size by Application (2017-2022)
9.3.2 Latin America Fibroadenoma Diagnosis Market Size by Application (2023-2028)
9.3.3 Latin America Fibroadenoma Diagnosis Market Share by Application (2017-2028)
9.4 Latin America Fibroadenoma Diagnosis Market Size by Country
9.4.1 Latin America Fibroadenoma Diagnosis Market Size by Country (2017-2022)
9.4.2 Latin America Fibroadenoma Diagnosis Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fibroadenoma Diagnosis Market Size (2017-2028)
10.2 Middle East & Africa Fibroadenoma Diagnosis Market Size by Type
10.2.1 Middle East & Africa Fibroadenoma Diagnosis Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Fibroadenoma Diagnosis Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Fibroadenoma Diagnosis Market Share by Type (2017-2028)
10.3 Middle East & Africa Fibroadenoma Diagnosis Market Size by Application
10.3.1 Middle East & Africa Fibroadenoma Diagnosis Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Fibroadenoma Diagnosis Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Fibroadenoma Diagnosis Market Share by Application (2017-2028)
10.4 Middle East & Africa Fibroadenoma Diagnosis Market Size by Country
10.4.1 Middle East & Africa Fibroadenoma Diagnosis Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Fibroadenoma Diagnosis Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 The Royal Woman’s Hospital
11.1.1 The Royal Woman’s Hospital Company Details
11.1.2 The Royal Woman’s Hospital Business Overview
11.1.3 The Royal Woman’s Hospital Fibroadenoma Diagnosis Introduction
11.1.4 The Royal Woman’s Hospital Revenue in Fibroadenoma Diagnosis Business (2017-2022)
11.1.5 The Royal Woman’s Hospital Recent Developments
11.2 Westmead Breast Cancer Institute
11.2.1 Westmead Breast Cancer Institute Company Details
11.2.2 Westmead Breast Cancer Institute Business Overview
11.2.3 Westmead Breast Cancer Institute Fibroadenoma Diagnosis Introduction
11.2.4 Westmead Breast Cancer Institute Revenue in Fibroadenoma Diagnosis Business (2017-2022)
11.2.5 Westmead Breast Cancer Institute Recent Developments
11.3 HCA Healthcare
11.3.1 HCA Healthcare Company Details
11.3.2 HCA Healthcare Business Overview
11.3.3 HCA Healthcare Fibroadenoma Diagnosis Introduction
11.3.4 HCA Healthcare Revenue in Fibroadenoma Diagnosis Business (2017-2022)
11.3.5 HCA Healthcare Recent Developments
11.4 Breast Cancer Now
11.4.1 Breast Cancer Now Company Details
11.4.2 Breast Cancer Now Business Overview
11.4.3 Breast Cancer Now Fibroadenoma Diagnosis Introduction
11.4.4 Breast Cancer Now Revenue in Fibroadenoma Diagnosis Business (2017-2022)
11.4.5 Breast Cancer Now Recent Developments
11.5 UFHealth
11.5.1 UFHealth Company Details
11.5.2 UFHealth Business Overview
11.5.3 UFHealth Fibroadenoma Diagnosis Introduction
11.5.4 UFHealth Revenue in Fibroadenoma Diagnosis Business (2017-2022)
11.5.5 UFHealth Recent Developments
11.6 KK Women’s and Children’s Hospital
11.6.1 KK Women’s and Children’s Hospital Company Details
11.6.2 KK Women’s and Children’s Hospital Business Overview
11.6.3 KK Women’s and Children’s Hospital Fibroadenoma Diagnosis Introduction
11.6.4 KK Women’s and Children’s Hospital Revenue in Fibroadenoma Diagnosis Business (2017-2022)
11.6.5 KK Women’s and Children’s Hospital Recent Developments
11.7 The Harley Street Breast Clinic
11.7.1 The Harley Street Breast Clinic Company Details
11.7.2 The Harley Street Breast Clinic Business Overview
11.7.3 The Harley Street Breast Clinic Fibroadenoma Diagnosis Introduction
11.7.4 The Harley Street Breast Clinic Revenue in Fibroadenoma Diagnosis Business (2017-2022)
11.7.5 The Harley Street Breast Clinic Recent Developments
11.8 National University Health System
11.8.1 National University Health System Company Details
11.8.2 National University Health System Business Overview
11.8.3 National University Health System Fibroadenoma Diagnosis Introduction
11.8.4 National University Health System Revenue in Fibroadenoma Diagnosis Business (2017-2022)
11.8.5 National University Health System Recent Developments
11.9 American Cancer Society
11.9.1 American Cancer Society Company Details
11.9.2 American Cancer Society Business Overview
11.9.3 American Cancer Society Fibroadenoma Diagnosis Introduction
11.9.4 American Cancer Society Revenue in Fibroadenoma Diagnosis Business (2017-2022)
11.9.5 American Cancer Society Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

H&I Global Research

線維腺腫診断の世界市場インサイト・予測（～2028年）

グローバル市場調査会社